Insulet (PODD) Price to Earnings (2010 - 2026)

Insulet (PODD) has reported Price to Earnings for 17 consecutive years, with 111.15 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Earnings fell 88.69% year-over-year to 111.15; the trailing twelve-month figure through Jun 2026 stood at 28.13 (down 69.96% YoY), and the FY2025 full-year result was 80.97, up 84.82% from the prior year.
• Price to Earnings fell to 111.15 in Q2 2026 per PODD's latest filing, from 159.54 in the prior quarter.
• Across five years, Price to Earnings topped out at 1203.73 in Q4 2022 and bottomed at 3062.98 in Q3 2022.
• Historically, Price to Earnings has averaged 184.72 across 5 years, with a median of 212.61 in 2023.
• The sharpest annual moves came in 2022 and 2025: Price to Earnings sank 297.01% in 2022, then jumped 1210.24% in 2025.
• Over 5 years, Price to Earnings stood at 1203.73 in 2022, then tumbled by 87.81% to 146.7 in 2023, then increased by 24.06% to 181.99 in 2024, then climbed by 8.1% to 196.73 in 2025, then plunged by 43.5% to 111.15 in 2026.
• According to Business Quant data, Price to Earnings over the past three periods registered 111.15, 159.54, and 196.73 for Q2 2026, Q1 2026, and Q4 2025 respectively.